Clinical Trial Update: Multicenter, Nonrandomized, Prospective Study of Pulmonary Embolism Removal With the AngioJet 6F Ultra System [Phase 4]

View source ↗

Summary

A multicenter, nonrandomized Phase 4 trial evaluating pulmonary embolism removal with the AngioJet 6F Ultra System has been terminated; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism

Drugs mentioned

• AngioJet 6F Ultra System

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Pulmonary Embolism | Phase 4 | Status: TERMINATED | Results posted: 2016-11-01